000 01128 a2200313 4500
005 20250513010107.0
264 0 _c19820917
008 198209s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1982.tb01898.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTimmis, A D
245 0 0 _aRole of labetalol in acute myocardial infarction.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cJun 1982
300 _a111S-114S p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aEthanolamines
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLabetalol
_xtherapeutic use
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aOxygen Consumption
700 1 _aFowler, M B
700 1 _aJaggarao, N S
700 1 _aVincent, R
700 1 _aChamberlain, D A
773 0 _tBritish journal of clinical pharmacology
_gvol. 13
_gno. 1 Suppl
_gp. 111S-114S
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1982.tb01898.x
_zAvailable from publisher's website
999 _c7092716
_d7092716